Drug firm Lupin on Friday said it has received approval from the US health regulator for generic Hydrocortisone Valerate cream used for relief from inflammation and itching due to various skin conditions.
The company has got approval for its Hydrocortisone Valerate cream USP, 0.2 per cent from the United States Food and Drug Administration (USFDA), Lupin said in a filing to the BSE.
The product is generic version of Sun Pharmaceutical Industries Ltd's Westcort cream in the same strength, it added.
The cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients, Lupin said.
Shares of Lupin Ltd on Friday ended at Rs 729.40 per scrip on the BSE, down 0.67 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
